Company News
Solara Reports No Deviation in Rights Issue Funds
Solara Active Pharma Sciences confirms no deviation in use of Rs 442.73 crore proceeds from its rights issue as per SEBI Regulation 32.
The Audit Committee reviewed and approved the utilization statem
